Multiple sclerosis is a rare yet progressively fatal autoimmune disorder of the central nervous system, and is characterized with visual loss, mobility issues and paralysis. While scientists are trying to figure out the exact cause of autoimmune destruction of the protective neural myelin sheath responsible for normal impulse conduction, analysis through brain scans and MRI has revealed the formation of brain lesions at multiple locations, mainly affecting the brain stem, the cerebellum, the spinal cord, and optic nerves. On a general note, depending upon relapse and remission, the disease is categorized into four main types, such as clinically isolated syndrome, relapse-remitting multiple sclerosis, primary progressive multiple sclerosis, and secondary progressive multiple sclerosis. Person experiencing multiple sclerosis, commonly reports symptoms such as muscle weakness, fatigue, bladder problems, vertigo and dizziness.

In a conventional set-up, there is still a lack of definitive treatment protocol, which can slow down the disease progression and/or reverse the root cause of development. But the modern medicine has come up with an option of Stem Cell Therapy for Multiple Sclerosis that can prevent further disease progression, offer the benefit of symptomatic relief to the patients and also, to some extent, reverse the neuronal damage to increase functional contribution.

Stem Cell Treatment for Multiple Sclerosis: Advancells Protocol

At Advancells, we have identified the unlimited potential of stem cells isolated from different Adult Autologous sources of human bodies, including Bone Marrow, Adipose Tissue, etc. With our advanced Technical Support, Scientific Excellence and Competent Quality Management System, we are focused to provide a comprehensive, personalized therapeutic solution that is best suited for individual requirements of people undergoing stem cell treatment for Multiple Sclerosis.

With extensive research these challenges are now comprehensible to therapeutic ventures resulting in new treatments of multiple sclerosis using autologous treatment/allogenic transplant for adipose-derived mesenchymal stromal cells treatment and bone marrow stromal cells treatment.

This new insight on the treatment of multiple sclerosis has helped in identifying the potential to overcome multiple sclerosis with stem cells, primarily using autologous stem cell transplant in form of hematopoietic stem cell transplant or mesenchymal stromal cells treatment.